214 related articles for article (PubMed ID: 24857251)
1. Impact of initial blood pressure on antihypertensive response in patients with acute hypertension.
Farias S; Peacock WF; Gonzalez M; Levy PD
Am J Emerg Med; 2014 Aug; 32(8):833-6. PubMed ID: 24857251
[TBL] [Abstract][Full Text] [Related]
2. The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine?
Varon J; Soto-Ruiz KM; Baumann BM; Borczuk P; Cannon CM; Chandra A; Cline DM; Diercks DB; Hiestand B; Hsu A; Jois-Bilowich P; Kaminski B; Levy P; Nowak RM; Schrock JW; Peacock WF
Postgrad Med; 2014 Jul; 126(4):124-30. PubMed ID: 25141250
[TBL] [Abstract][Full Text] [Related]
3. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.
Peacock WF; Varon J; Baumann BM; Borczuk P; Cannon CM; Chandra A; Cline DM; Diercks D; Hiestand B; Hsu A; Jois-Bilowich P; Kaminski B; Levy P; Nowak RM; Schrock JW
Crit Care; 2011; 15(3):R157. PubMed ID: 21707983
[TBL] [Abstract][Full Text] [Related]
4. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Malesker MA; Hilleman DE
J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of patients that do not initially respond to intravenous antihypertensives in the emergency department: subanalysis of the CLUE trial.
Freiermuth CE; Chandra A; Peacock WF;
West J Emerg Med; 2015 Mar; 16(2):276-83. PubMed ID: 25834670
[TBL] [Abstract][Full Text] [Related]
6. Clevidipine: a review of its use in the management of acute hypertension.
Deeks ED; Keating GM; Keam SJ
Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
[TBL] [Abstract][Full Text] [Related]
7. Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study.
Ryu JH; Apfel CC; Whelan R; Jeon YT; Hwang JW; Do SH; Ro YJ; Kim CS
Clin Ther; 2012 Mar; 34(3):593-604. PubMed ID: 22364823
[TBL] [Abstract][Full Text] [Related]
8. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation.
Narotam PK; Puri V; Roberts JM; Taylon C; Vora Y; Nathoo N
J Neurosurg; 2008 Dec; 109(6):1065-74. PubMed ID: 19035721
[TBL] [Abstract][Full Text] [Related]
9. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
Hecht JP; Richards PG
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
11. Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
McKay C; Hall AB; Cortes J
J Neurosci Nurs; 2015 Dec; 47(6):327-32. PubMed ID: 26528950
[TBL] [Abstract][Full Text] [Related]
12. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
14. Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial.
Potter J; Mistri A; Brodie F; Chernova J; Wilson E; Jagger C; James M; Ford G; Robinson T
Health Technol Assess; 2009 Jan; 13(9):iii, ix-xi, 1-73. PubMed ID: 19208305
[TBL] [Abstract][Full Text] [Related]
15. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol.
Elatrous S; Nouira S; Ouanes Besbes L; Marghli S; Boussarssar M; Sakkouhi M; Abroug F
Intensive Care Med; 2002 Sep; 28(9):1281-6. PubMed ID: 12209278
[TBL] [Abstract][Full Text] [Related]
16. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.
Potter JF; Robinson TG; Ford GA; Mistri A; James M; Chernova J; Jagger C
Lancet Neurol; 2009 Jan; 8(1):48-56. PubMed ID: 19058760
[TBL] [Abstract][Full Text] [Related]
17. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral hemorrhage: the ACCELERATE trial.
Graffagnino C; Bergese S; Love J; Schneider D; Lazaridis C; LaPointe M; Lee K; Lynch G; Hu MY; Williams GC
Cerebrovasc Dis; 2013; 36(3):173-80. PubMed ID: 24135526
[TBL] [Abstract][Full Text] [Related]
18. Early Achievement of Blood Pressure Lowering and Hematoma Growth in Acute Intracerebral Hemorrhage: Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement-Intracerebral Hemorrhage Study.
Yamaguchi Y; Koga M; Sato S; Yamagami H; Todo K; Okuda S; Okada Y; Kimura K; Shiokawa Y; Kamiyama K; Itabashi R; Hasegawa Y; Kario K; Fujita K; Kumamoto M; Kamimura T; Ando D; Ide T; Yoshimoto T; Shiozawa M; Matsubara S; Yoshimura S; Nagatsuka K; Toyoda K;
Cerebrovasc Dis; 2018; 46(3-4):118-124. PubMed ID: 30199854
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
